Lobe Sciences Ltd. (CSE: LOBE)

Canada flag Canada · Delayed Price · Currency is CAD
0.0200
+0.0050 (33.33%)
Nov 22, 2024, 4:00 PM EST
0.00%
Market Cap 3.43M
Revenue (ttm) 976.74K
Net Income (ttm) -2.97M
Shares Out 171.56M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 48,033
Open 0.0200
Previous Close 0.0150
Day's Range 0.0200 - 0.0200
52-Week Range 0.0100 - 0.0250
Beta 2.28
Analysts n/a
Price Target n/a
Earnings Date Dec 20, 2024

About Lobe Sciences

Lobe Sciences Ltd., a biopharmaceutical company, focuses on the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Frederick Sancilio
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol LOBE
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.